| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bf7439808d578ab8c3698f7560fe4ab |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 |
| filingDate |
1994-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1996-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af34a491b7043c1fc3bc1a50beef685c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_632b55278ae950f21c60d62c2655836e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdbde830a73be97b3d91984238c66303 |
| publicationDate |
1996-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5527825-A |
| titleOfInvention |
Method of treating schizophrenia, tourette's syndrome, mania, autism, and obsessive compulsive disorder with inhibitors of brain nitric oxide synthase |
| abstract |
The present invention provides a pharmaceutical compositions suitable for the treatment of brain diseases characterized by excessive activity of brain dopamine systems and/or nitric oxide systems. Also provided is a method of treating psychiatric and neurologic diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007034214-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6790825-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6020310-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6498143-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9442092-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7091182-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005249714-A1 |
| priorityDate |
1994-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |